OBJECTIVE: To compare four sampling methods: blind tracheal aspirate (blind TA), blind protected telescoping catheter (blind PTC), bronchoscopic PTC and bronchoscopic bronchoalveolar lavage (bronchoscopic BAL), for diagnosis of ventilator-associated pneumonia (VAP). DESIGN: Prospective multicentre study. SETTING: Five intensive care units in France. PATIENTS: Sixty-three patients with mechanical ventilation for more than 48 h, no recent antibiotic change (<72 h) and suspected nosocomial pneumonia. INTERVENTIONS: All patients underwent the four sampling methods. Direct examination and quantitative cultures of the four specimens were performed. MEASUREMENTS AND RESULTS: Visible secretions expelled from the catheter were present 40 times (63%) for blind PTC and 45 times (71%) for bronchoscopic PTC. After exclusion of 11 uncertain cases, 34 VAP were diagnosed. Direct examination of PTC (either blind or bronchoscopic) did not differ from direct examination of bronchoscopic BAL in predicting VAP diagnosis and in guiding initial antibiotic treatment correctly. Compared to that of bronchoscopic BAL (0.98), the area under receiver operating characteristics (ROC) curve was smaller for blind TA (0.78, p=0.002), blind PTC (0.83, p=0.009) and bronchoscopic PTC (0.85, p=0.01). When samples with visible secretions expelled from the catheter were considered, blind and bronchoscopic PTC had areas under ROC curve close to that of bronchoscopic BAL (0.90, p=0.22 and 0.91, p=0.27, respectively). CONCLUSIONS: Blind PTC appears to be a good alternative to bronchoscopic sampling for VAP diagnosis, provided that the sample contains visible secretions expelled from the catheter.
OBJECTIVE: To compare four sampling methods: blind tracheal aspirate (blind TA), blind protected telescoping catheter (blind PTC), bronchoscopic PTC and bronchoscopic bronchoalveolar lavage (bronchoscopic BAL), for diagnosis of ventilator-associated pneumonia (VAP). DESIGN: Prospective multicentre study. SETTING: Five intensive care units in France. PATIENTS: Sixty-three patients with mechanical ventilation for more than 48 h, no recent antibiotic change (<72 h) and suspected nosocomial pneumonia. INTERVENTIONS: All patients underwent the four sampling methods. Direct examination and quantitative cultures of the four specimens were performed. MEASUREMENTS AND RESULTS: Visible secretions expelled from the catheter were present 40 times (63%) for blind PTC and 45 times (71%) for bronchoscopic PTC. After exclusion of 11 uncertain cases, 34 VAP were diagnosed. Direct examination of PTC (either blind or bronchoscopic) did not differ from direct examination of bronchoscopic BAL in predicting VAP diagnosis and in guiding initial antibiotic treatment correctly. Compared to that of bronchoscopic BAL (0.98), the area under receiver operating characteristics (ROC) curve was smaller for blind TA (0.78, p=0.002), blind PTC (0.83, p=0.009) and bronchoscopic PTC (0.85, p=0.01). When samples with visible secretions expelled from the catheter were considered, blind and bronchoscopic PTC had areas under ROC curve close to that of bronchoscopic BAL (0.90, p=0.22 and 0.91, p=0.27, respectively). CONCLUSIONS: Blind PTC appears to be a good alternative to bronchoscopic sampling for VAP diagnosis, provided that the sample contains visible secretions expelled from the catheter.
Authors: A Torres; J Puig de la Bellacasa; A Xaubet; J Gonzalez; R Rodríguez-Roisin; M T Jiménez de Anta; A Agustí Vidal Journal: Am Rev Respir Dis Date: 1989-08
Authors: Jan Hayon; Corinne Figliolini; Alain Combes; Jean-Louis Trouillet; Najibi Kassis; Marie Christine Dombret; Claude Gibert; Jean Chastre Journal: Am J Respir Crit Care Med Date: 2002-01-01 Impact factor: 21.405
Authors: S R Leal-Noval; E Alfaro-Rodríguez; F Murillo-Cabeza; J Garnacho-Montero; J Rey-Perez; M A Múñoz-Sánchez Journal: Intensive Care Med Date: 1992 Impact factor: 17.440
Authors: J J Rouby; E Martin De Lassale; P Poete; M H Nicolas; L Bodin; V Jarlier; Y Le Charpentier; J Grosset; P Viars Journal: Am Rev Respir Dis Date: 1992-10
Authors: Anne Veinstein; Christian Brun-Buisson; Nicolas Derrode; Antonio Alvarez; Michel Pinsard; René Robert; François Blot Journal: Intensive Care Med Date: 2006-03-07 Impact factor: 17.440
Authors: Johannes B J Scholte; Helke A van Dessel; Catharina F M Linssen; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook Journal: J Clin Microbiol Date: 2014-07-30 Impact factor: 5.948
Authors: Ivor S Douglas; Connie S Price; Katherine H Overdier; Robert F Wolken; Steven W Metzger; Kenneth R Hance; David C Howson Journal: Am J Respir Crit Care Med Date: 2015-03-01 Impact factor: 21.405
Authors: Mark A Jonker; Tina M Sauerhammer; Lee D Faucher; Michael J Schurr; Kenneth A Kudsk Journal: Surg Infect (Larchmt) Date: 2012-12-16 Impact factor: 2.150
Authors: P P Roeleveld; D Guijt; E J Kuijper; M G Hazekamp; R B P de Wilde; E de Jonge Journal: Intensive Care Med Date: 2011-08-30 Impact factor: 17.440
Authors: A B Chang; N C Cox; J Purcell; J M Marchant; P J Lewindon; G J Cleghorn; L C Ee; G D Withers; M K Patrick; J Faoagali Journal: Respir Res Date: 2005-07-15
Authors: Ricardo de Amorim Corrêa; Carlos Michel Luna; José Carlos Fernandez Versiani dos Anjos; Eurípedes Alvarenga Barbosa; Cláudia Juliana de Rezende; Adriano Pereira Rezende; Fernando Henrique Pereira; Manoel Otávio da Costa Rocha Journal: J Bras Pneumol Date: 2014 Nov-Dec Impact factor: 2.624
Authors: Alvaro Rea-Neto; Nazah Cherif M Youssef; Fabio Tuche; Frank Brunkhorst; V Marco Ranieri; Konrad Reinhart; Yasser Sakr Journal: Crit Care Date: 2008-04-21 Impact factor: 9.097